Cure My Disease

Don't miss your cure!

 Log in / Sign up

New cheaper cancer drug alternative enters final testing phase

NCT ID NCT07221734

Recruiting now Disease control Sponsor: mAbxience Research S.L. Source: ClinicalTrials.gov ↗

Summary

This study is testing if a new drug called MB11 works the same as the established cancer drug Opdivo (nivolumab) for people with advanced melanoma that cannot be removed by surgery or has spread. It's a large, late-stage trial involving 632 adults who have not yet received treatment for their advanced cancer. The main goal is to see if MB11 is equivalent to Opdivo in how the body processes it and how well it controls the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED (UNRESECTABLE OR METASTATIC) MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Site 111003

    RECRUITING

    Funchal, Portugal

  • Site 117002

    RECRUITING

    Kyiv, Ukraine

  • Site 117003

    RECRUITING

    Ternopil, Ukraine

  • Site 117004

    RECRUITING

    Uzhhorod, Ukraine

  • Site 117005

    RECRUITING

    Ivano-Frankivsk, Ukraine

  • Site 117006

    RECRUITING

    Kyiv, Ukraine

  • Site 117007

    RECRUITING

    Kyiv, Ukraine

  • Site 117010

    RECRUITING

    Uzhhorod, Ukraine

  • Site 117012

    RECRUITING

    Kyiv, Ukraine

  • Site 117013

    RECRUITING

    Kyiv, Ukraine

  • Site 117014

    RECRUITING

    Kyiv, Ukraine

  • Site 117015

    RECRUITING

    Chernivtsi, Ukraine

  • Site 117016

    RECRUITING

    Kyiv, Ukraine

  • Site 117017

    RECRUITING

    Kyiv, Ukraine

  • Site 117018

    RECRUITING

    Kyiv, Ukraine

  • Site 117019

    RECRUITING

    Uzhhorod, Ukraine

  • Site 117020

    RECRUITING

    Kyiv, Ukraine

  • Site 117021

    RECRUITING

    Kyiv, Ukraine

  • Site 117022

    RECRUITING

    Lutsk, Ukraine

Conditions

Explore the condition pages connected to this study.

ADVANCED (UNRESECTABLE OR METASTATIC) MELANOMA